摘要 |
The present invention relates to a low dose composition of budesonide suitable for administration of budesonide to mucosal membranes for the management of nasal symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis, perennial non-allergic rhinitis, nasal polyps, as well as prevention of post surgical polyps, chronic sinusitis and recurrent sinusitis comprising budesonide at a therapeutically effective dose of less than 16 mcg and a pharmaceutically acceptable liquid carrier. |
申请人 |
SUN PHARMACEUTICAL INDUSTRIES LIMITED;BHOWMICK, BALARAM, SUBHAS;LADDHA, NITIN, RITU;KHOPADE, JAYSINGH, AJAY |
发明人 |
BHOWMICK, BALARAM, SUBHAS;LADDHA, NITIN, RITU;KHOPADE, JAYSINGH, AJAY |